SPONSORED BY
general information
The Academic Drug Discovery Consortium (ADDC) and the University of San Francisco School of Medicine cordially invite you to join us for the ADDC 2027 Colloquium.
Pharmacologists, medicinal chemists, drug discovery scientists, in vitro/in vivo scientists, DMPK experts, trainees and scientists from industry, academia, contract research organizations, biotech, pharma, research institutes, accelerators/incubators, foundations and government with an interest in drug discovery area are all welcome to this colloquium. REGISTRATIONColloquium registration fees include access to all keynotes, scientific talks, and poster sessions as well as all food functions listed in the final Colloquium schedule.
| QUICK LINKSIMPORTANT DATES
|
MEETING LOCATION
The ADDC 2027 Colloquium will be held in the Fisher Banquet Room at the UCSF Mission Bay Conference Center, located at 1675 Owens St Unit 251, San Francisco, CA 94158.
SPONSORSHIPInterested in partnering with us? Review our ADDC Colloquium Sponsorship Brochure to find out more. If you have questions or are ready to confirm your sponsorship, contact us at: manager@addconsortium.org 305-661-5581 |
Organizing Committee
Cancellation / Transfer Policy
- From registration date to February 28, 2027, paid delegates may cancel their registration with full refund, less a $100 cancellation fee. All cancellations must be provided in writing and emailed to manager@addconsortium.org. Cancellations are considered complete once you receive an official reply from ADDC with confirming details. After March 1, 2027, no refunds will be given for any cancellations or no-shows. We regret that we cannot refund any fees after the deadline, as we must submit complete commitments for our meeting vendors.
- To transfer your registration to another individual, email your request and include the name of the person attending in your place, their email address and cc them on your request. Transfers are considered complete once you receive an official reply from ADDC with confirming details.